Izun Pharmaceuticals
Professor, Harvard-Forsyth Oral Biology, Harvard School of Dental Medicine, Dana-Farber Cancer Institute, Brigham and Women’s Hospital. A world-renowned expert in epithelial injury associated with cancer therapy. Dr. Sonis is the former President of Triad, which focused on the adverse health and economic outcomes of cancer treatment toxicities, and serves as a special government employee of the FDA.
This person is not in the org chart
This person is not in any offices
Izun Pharmaceuticals
Izun Pharmaceuticals develops non-steroidal topical oral anti-inflammatory therapies for periodontal treatments.